NAMSA Executive and Leadership Team

Scott Sellick, the Chief Financial Officer at NAMSA, directs all financial operations and strategic fiscal planning. Sellick oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health and resource allocation across the organization. This leadership position involves managing investment strategies and optimizing financial performance to support NAMSA's growth objectives. By maintaining stringent financial controls and driving cost efficiencies, Scott Sellick directly contributes to the company's long-term stability and its capacity to fund critical research and development initiatives. The Chief Financial Officer's oversight extends to managing relationships with financial institutions and stakeholders, securing capital for expansion and operational enhancements.

Elizabeth Kempen, the Chief Operating Officer at NAMSA, executes operational strategies to enhance service delivery and efficiency. Kempen manages the day-to-day operations of the organization, focusing on streamlining processes within laboratory services, clinical research, and consulting divisions. This role involves optimizing resource utilization and ensuring seamless integration of services to accelerate medical device product development for clients. By driving operational excellence, Elizabeth Kempen directly supports NAMSA's mission to expedite market entry for innovative medical technologies. The Chief Operating Officer's responsibilities include overseeing quality management systems and implementing best practices across all operational functions, ensuring compliance and client satisfaction.

Gina Skolmowski, the Global Division President, Laboratory Services at NAMSA, directs the strategic growth and operational excellence of the company's laboratory divisions. Skolmowski oversees all aspects of laboratory operations, ensuring the delivery of high-quality, compliant testing services that accelerate medical device development. This leadership role involves managing global laboratory teams, optimizing testing methodologies, and implementing advanced technologies to enhance service capabilities. By driving innovation and efficiency within the laboratories, Gina Skolmowski directly supports clients in bringing safer and more effective medical devices to market. The Global Division President's focus includes expanding service offerings, ensuring regulatory adherence, and maintaining NAMSA's reputation for scientific rigor.

Andrew Suri, the Lead Business Development Executive & Chief Revenue Officer at NAMSA, drives revenue generation and market expansion initiatives. Suri leads the business development teams, focusing on identifying new market opportunities and cultivating strategic client relationships across the medical device industry. This executive role involves developing and implementing comprehensive revenue strategies to achieve ambitious growth targets. By fostering strong partnerships and understanding client needs, Andrew Suri directly enhances NAMSA's market position and service adoption. The Chief Revenue Officer's purview includes overseeing sales pipelines, optimizing pricing strategies, and ensuring alignment between market demands and NAMSA's service offerings.

Alexa Liantonio, the Senior Global Business Development Executive & Chief Revenue Officer at NAMSA, spearheads global revenue growth and strategic market penetration. Liantonio directs international business development efforts, focusing on expanding NAMSA's footprint in key global markets and securing significant client engagements. This leadership position involves cultivating high-value partnerships and driving the adoption of NAMSA's integrated services. By championing client success and identifying emerging trends, Alexa Liantonio directly amplifies the company's impact on medical device innovation worldwide. The Chief Revenue Officer's strategic focus includes developing and executing global sales strategies, managing international sales teams, and ensuring consistent revenue performance across diverse regions.

Roseanne Sawyer, the Chief Human Resources Officer at NAMSA, shapes the organizational culture and talent strategy. Sawyer oversees all human resources functions, including talent acquisition, employee development, compensation, and benefits, ensuring a high-performing and engaged workforce. This critical role focuses on attracting and retaining top scientific and operational talent essential for NAMSA's specialized services. By fostering a supportive and innovative work environment, Roseanne Sawyer directly contributes to the company's ability to deliver cutting-edge solutions. The Chief Human Resources Officer's strategic priorities include implementing robust HR policies, driving employee engagement initiatives, and aligning human capital with the company's long-term business objectives.

Adam Saltman, the Chief Medical Officer, At Namsa, provides critical medical and scientific leadership to guide product development strategies. Saltman oversees the clinical aspects of NAMSA's services, ensuring that research and development efforts align with medical best practices and regulatory requirements. This executive position involves offering expert insights into clinical trial design, data interpretation, and the overall medical viability of new devices. By bridging the gap between scientific innovation and clinical application, Adam Saltman directly enhances the value NAMSA provides to its clients. The Chief Medical Officer's responsibilities include advising on therapeutic areas, contributing to regulatory submissions, and ensuring the scientific integrity of all research conducted.